Choi WS, Lee JI, Yoon HJ, Min CK, Lee SH. Medication-related osteonecrosis of the jaw: a preliminary retrospective study of 130 patients with multiple myeloma. Maxillofac Plast Reconstr Surg. 2017;39:1.
Auzina D, Slaidina A, Sevastjanova M, Erts R, Lejnieks A, Lejniece S. A population based study of multiple myeloma patients with medication-related osteonecrosis of the jaw. Stomatologija. 2019;21:13–7.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg. 2014;72:1938–56.
Fusco V, Cabras M, Erovigni F, Dell’Acqua A, Arduino PG, Pentenero M, et al. A multicenter observational study on medication-related osteonecrosis of the jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy. Med Oral Patol Oral Cir Bucal. 2021;26:e466–73.
Bacci C, Cerrato A, Dotto V, Zambello R, Barilà G, Liço A, et al. The importance of alliance between hematologists and dentists: a retrospective study on the development of bisphosphonates osteonecrosis of the jaws (Bronj) in multiple myeloma patients. Dent J (Basel). 2021;9:11.
Ogura I, Kobayashi E, Nakahara K, Haga-Tsujimura M, Igarashi K, Katsumata A. Computer programme to assess mandibular cortex morphology in cases of medication-related osteonecrosis of the jaw with osteoporosis or bone metastases. Imaging Sci Dent. 2019;49:281–6.
Ogura I, Minami Y, Ono J, Kanri Y, Okada Y, Igarashi K, et al. CBCT imaging and histopathological characteristics of osteoradionecrosis and medication-related osteonecrosis of the jaw. Imaging Sci Dent. 2021;51:73–80.
Ogura I, Sasaki Y, Kameta A, Sue M, Oda T. Characteristic multimodal imaging of medication-related osteonecrosis of the jaw: comparison between oral and parenteral routes of medication administration. Pol J Radiol. 2017;82:551–60.
Ogura I, Sasaki Y, Sue M, Oda T, Kameta A, Hayama K. Tc-99m hydroxymethylene diphosphonate scintigraphy, computed tomography, and magnetic resonance imaging of osteonecrosis in the mandible: osteoradionecrosis versus medication-related osteonecrosis of the jaw. Imaging Sci Dent. 2019;49:53–8.
Ogura I, Kobayashi E, Nakahara K, Igarashi K, Haga-Tsujimura M, Toshima H. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis. Ann Nucl Med. 2019;33:776–82.
Ogura I, Sasaki Y, Sue M, Oda T, Kameta A, Hayama K. Tc-99m hydroxymethylene diphosphonate SPECT/CT for the evaluation of osteonecrosis of the jaw: preliminary study on diagnostic ability of maximum standardized uptake value. Clin Radiol. 2020;75:46–50.
Toshima H, Ogura I. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value. Dentomaxillofac Radiol. 2020;49:20200043.
Minami Y, Ogura I. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw. J Med Imaging Radiat Oncol. 2021;65:160–5.
Ogawa R, Ogura I. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value. Dentomaxillofac Radiol. 2021;50:20200516.
Vanpoecke J, Verstraete L, Smeets M, Ferri J, Nicot R, Politis C. Medication-related osteonecrosis of the jaw (MRONJ) stage III: conservative and conservative surgical approaches versus an aggressive surgical intervention: a systematic review. J Craniomaxillofac Surg. 2020;48:435–43.
Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M, et al. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw. Dentomaxillofac Radiol. 2018;47:20170323.
Marx RE, Tursun R. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease. Int J Oral Maxillofac Surg. 2012;41:283–9.
Shuster A, Reiser V, Trejo L, Ianculovici C, Kleinman S, Kaplan I. Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis. Int J Oral Maxillofac Surg. 2019;48:17–22.
Junquera S, Alvarez-Yague E, Junquera L, Ugalde R, Rua L. Multiple myeloma and chemical maxillary osteonecrosis. Can both occur simultaneously? J Stomatol Oral Maxillofac Surg. 2020;121:523–6.
Lu SY, Ma MC, Wang MC, Hsue SS. The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma. J Formos Med Assoc. 2021;S0929–6646(21):00037–41.
